Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.
作者信息
Manno Girolamo, Novo Giuseppina, Corrado Egle, Coppola Giuseppe, Novo Salvatore
机构信息
Department of Emergency and Urgency, Biomedic Department of Internal Medicine and Specialities (DIBIMIS).
Chair and Post/Graduate School of Cardiovascular Diseases, Department for Promoting Health (PROSAMI), Division of Cardiology, University Hospital 'Paolo Giaccone' of Palermo, Palermo, Italy.
出版信息
J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):403-405. doi: 10.2459/JCM.0000000000000752.
PMID:30762659
Abstract
摘要
相似文献
1
Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.
J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):403-405. doi: 10.2459/JCM.0000000000000752.
2
Predictors for a high apixaban level in elderly patients with atrial fibrillation prescribed reduced dose of apixaban.
Eur J Clin Pharmacol. 2021 Nov;77(11):1757-1758. doi: 10.1007/s00228-021-03135-8. Epub 2021 May 20.
3
Acquired Hemophilia A in an Elderly Patient on Apixaban Therapy.
Isr Med Assoc J. 2021 Feb;23(2):130-131.
4
Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.
Arch Cardiovasc Dis. 2018 May;111(5):349-356. doi: 10.1016/j.acvd.2017.07.005. Epub 2017 Nov 27.
5
Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia.
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):494-501. doi: 10.1177/1074248418778544. Epub 2018 May 23.
6
Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
J Cardiovasc Electrophysiol. 2016 Feb;27(2):147-53. doi: 10.1111/jce.12856. Epub 2015 Nov 23.
7
Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study.
J Cardiovasc Pharmacol Ther. 2020 Nov;25(6):523-530. doi: 10.1177/1074248420929483. Epub 2020 Jun 1.
8
Critical appraisal of the AUGUSTUS trial.
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):187-188. doi: 10.1093/ehjcvp/pvz017.
9
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
Europace. 2017 Jan;19(1):132-138. doi: 10.1093/europace/euw368.
10
A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruption.
Anatol J Cardiol. 2016 Mar;16(3):213-5. doi: 10.14744/AnatolJCardiol.2016.6774.
引用本文的文献
1
Failure of non-vitamin K antagonist oral anticoagulants in preventing stroke in elderly patient: a case report of multiple strokes on standard of care treatment for atrial fibrillation.
Arch Clin Cases. 2021 Oct 27;8(1):1-6. doi: 10.22551/2021.30.0801.10177. eCollection 2021.
2
Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion.
Medicina (Kaunas). 2019 Sep 30;55(10):660. doi: 10.3390/medicina55100660.
Zotero 插件